Prenetics director reports 7,595 RSUs vesting 2027
Prenetics Global Ltd (PRE) reports the initial equity holdings of director Caroline S. Levy.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Prenetics Global Ltd (PRE) reports the initial equity holdings of director Caroline S. Levy. She holds 7,595 Restricted Stock Units (RSUs), each representing a contingent right to receive one Class A ordinary share. These RSUs vest on August 17, 2027, subject to continued service, and expire on August 17, 2033.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Unit F1 | -- | -- | -- |
Footnotes (1)
- F1. Each Restricted Stock Unit ("RSU"), granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. 7,595 RSUs vest on August 17, 2027, subject to continued service. Upon vesting, the RSUs are settled and delivered in shares.
Key Figures
Key Terms
Restricted Stock Unit financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is the reporting person in Prenetics Global Ltd (PRE)'s Form 3?
What equity awards in PRE does Caroline S. Levy report on this Form 3?
When do Caroline S. Levy’s 7,595 RSUs in PRE vest?
What is the exercise or conversion price of the RSUs reported for PRE?
When do the RSUs held by Caroline S. Levy in PRE expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.